Phillip J. Read

3.7k citations

117 papers · 2.9k · 1 hit paper · h-index 30

Impact in

Hepatology top 1%
- Hepatitis C virus research
Microbiology top 1%
- Reproductive tract infections research

Papers in

Hepatology 35
- Hepatitis C virus research 35
Microbiology 21
- Reproductive tract infections research 21

Co-authors: Anna M. McNulty (25 shared papers)Basil J Donovan (15 shared papers)Gregory J. Dore (25 shared papers)Christopher Bourne (7 shared papers)Rebecca Guy (18 shared papers)Christopher Kincaid Fairley (8 shared papers)Eric P. F. Chow (3 shared papers)Karen J. Chronister (5 shared papers)
Journals: Sexual Health (13 papers)International Journal of Drug Policy (12 papers)Clinical Infectious Diseases (8 papers)Drug and Alcohol Review (6 papers)Sexually Transmitted Infections (6 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

Phillip J. Read

108 papers receiving 2.8k citations

Phillip J. Read's Hit Papers

align trajectories log scale

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study 2018 · 295 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2018 The Lancet HIV

Peers

Countries citing papers authored by Phillip J. Read

Since Specialization

Citations

This map shows the geographic impact of Phillip J. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip J. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip J. Read more than expected).

Fields of papers citing papers by Phillip J. Read

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip J. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip J. Read. The network helps show where Phillip J. Read may publish in the future.

Co-authors

The 25 scholars most cited alongside Phillip J. Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phillip J. Read Line = papers co-authored together Phillip J. Read links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study The Lancet HIV ·Andrew Edwin Grulich, Rebecca Guy, Janaki Amin, Fengyi Jin, Christine Selvey, Heather-Marie Ann Schmidt, Iryna Zablotska, Karen L. Price Hit paper breakdown →	2018	295
2	Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial The Lancet. Gastroenterology & hepatology ·Jason Grebely, Olav Dalgård, Brian Conway, Evan B. Cunningham, Philip Bruggmann, Behzad Hajarizadeh, Janaki Amin, Julie Bruneau	2018	233
3	Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials Neurology ·Enchi Liu, Mark E. Schmidt, Richard A. Margolin, Reisa Anne Sperling, Robert A. Koeppe, Neale Scott Mason, William E. Klunk, Chester A. Mathis	2015	135
4	Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting International Journal of Drug Policy ·Phillip J. Read, Rebecca Lothian, Karen J. Chronister, Rosie Gilliver, John Kearley, Gregory J. Dore, Ingrid van Beek	2017	128
5	Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods Journal of Medical Microbiology ·JOHN W. TAPSALL, Phillip J. Read, Christopher Carmody, Christopher Bourne, Sanghamitra Ray, Athena E. Limnios, Theo P. Sloots, David M. Whiley	2009	120
6	Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidence Sexual Health ·David James Templeton, Phillip J. Read, Rajesh Varma, Christopher Bourne	2014	86
7	Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study The Lancet HIV ·Andrew Edwin Grulich, Fengyi Jin, Benjamin Robert Bavinton, Barbara Yeung, Mohamed Hammoud, Janaki Amin, Gesalit Cabrera, Shawn Clackett	2021	79
8	Increased Syphilis Testing of Men Who Have Sex With Men: Greater Detection of Asymptomatic Early Syphilis and Relative Reduction in Secondary Syphilis Clinical Infectious Diseases ·Eric P. F. Chow, Denton Callander, Christopher Kincaid Fairley, Lei Zhang, Basil J Donovan, Rebecca Guy, David A. Lewis, Margaret Elena Hellard	2017	77
9	Increasing trends of syphilis among men who have sex with men in high income countries Sexual Health ·Phillip J. Read, Christopher Kincaid Fairley, Eric P. F. Chow	2015	74
10	We know DAA s work, so now what? Simplifying models of care to enhance the hepatitis C cascade Journal of Internal Medicine ·Jeffrey Victor Lazarus, Juan Manuel Pericàs, Camila Andrea Picchio, Jasna Černoša, Miriam Hoekstra, Niklas Luhmann, Mojca Matičič, Phillip J. Read	2019	74
11	Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy PLoS ONE ·Hamish McManus, Catherine C O'Connor, Mark Alastair Boyd, Jennifer K. Broom, Darren B. Russell, Kerrie Watson, Norman Roth, Phillip J. Read	2012	71
12	When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? AIDS ·Phillip J. Read, Sundhiya Mandalia, Palwasha Yousafzai Khan, U. Harrisson, Claire M. Naftalin, Yvonne C. Gilleece, Jane Anderson, DAVID A. HAWKINS	2012	70
13	Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study International Journal of Drug Policy ·Evan B. Cunningham, Janaki Amin, Jordan J. Feld, Julie Bruneau, Olav Dalgård, Jeff E. Powis, Margaret Elena Hellard, Curtis Cooper	2018	64
14	Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study Clinical Infectious Diseases ·Heather Valerio, Maryam Nasseri Alavi, D. B. A. Silk, Carla Treloar, Marianne Martinello, Andrew Milat, Adrian John Dunlop, Charles Richmond Henderson	2020	63
15	Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy Clinical Infectious Diseases ·Evan B. Cunningham, Janaki Amin, Alain H. Litwin, Edward John Gane, Curtis Cooper, Karine Lacombe, Phillip J. Read, Olav Dalgård	2019	62
16	Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study Clinical Infectious Diseases ·Marianne Martinello, Jasmine Yee, Sofia R. Bartlett, Phillip J. Read, David A Baker, Jeffrey John Post, Robert James Finlayson, Mark Bloch	2019	59
17	Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis Clinical Infectious Diseases ·Jason Grebely, Lucy Thi Tran, Louisa J Degenhardt, Alexander Dowell‐Day, Thomas Santo, Sarah Larney, Matthew Hickman, Peter T. Vickerman	2020	56
18	Clinical aspects of adult syphilis Internal Medicine Journal ·Phillip J. Read, Basil J Donovan	2012	52
19	One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500 mg ceftriaxone in Sydney, Australia Sexual Health ·Phillip J. Read, E. Athena Limnios, Anna M. McNulty, David M. Whiley, Monica Moses Lahra	2013	50
20	Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study International Journal of Drug Policy ·Alison D. Marshall, Michelle A. Micallef, Amanda Erratt, Joanne Telenta, Carla Treloar, Hope Everingham, Sandra Carol Jones, Nicky Bath	2015	50

About Phillip J. Read

Phillip J. Read is a scholar working on Hepatology, Microbiology, Infectious Diseases, Epidemiology and Virology, having authored 117 papers that have together received 2.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (35 papers), Reproductive tract infections research (21 papers), HIV/AIDS Research and Interventions (13 papers), HIV, Drug Use, Sexual Risk (13 papers), Syphilis Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Sex work and related issues (5 papers). The work is most often cited by research in Hepatology (1.0k citations), Microbiology (441 citations), Infectious Diseases (714 citations), Epidemiology (797 citations) and Virology (113 citations). Phillip J. Read has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Anna M. McNulty, Basil J Donovan, Gregory J. Dore, Christopher Bourne, Rebecca Guy, Christopher Kincaid Fairley, Eric P. F. Chow, Karen J. Chronister, David M. Whiley and David James Templeton. Their work appears in journals such as Sexual Health, International Journal of Drug Policy, Clinical Infectious Diseases, Drug and Alcohol Review and Sexually Transmitted Infections.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Phillip J. Read

Impact in

Papers in i

In The Last Decade

Phillip J. Read

Phillip J. Read's Hit Papers

Peers

Countries citing papers authored by Phillip J. Read

Fields of papers citing papers by Phillip J. Read

All Works

About Phillip J. Read

Explore authors with similar magnitude of impact

Papers in